MELIORA Data Collection Campaigns
NCT07190066 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300
Last updated 2025-09-30
Summary
To support the development of the MELIORA digital app for the MELIORA main intervention, an initial pilot study (Data Collection Campaign, DCC) is being conducted with the three target participant groups: healthy women at increased risk of developing breast cancer (BC), BC patients, and BC survivors across the four intervention countries (Spain, Greece, Lithuania, Sweden). The planned sample size for each group is 156 healthy women at risk (defined as not meeting recommendations for a healthy lifestyle), 58 BC patients, and 86 BC survivors. Each participant is asked to test and evaluate a preliminary version of the MELIORA app over a 14-day period. The DCC takes place in the early stages of the project, as part of the intervention development phase, to inform the technical refinement and preliminary evaluation of the MELIORA digital app.
Conditions
- Breast Cancer Prevention
Interventions
- OTHER
-
Data Collection campaign
Participants will be asked to download the MELIROA app, compatible with iOS and Android, to their smartphones and test it for 14 days. The app will prompt the user to set a weekly goal on physical activity and support daily self-monitoring and step count tracking. Τhe app will also offer culturally adapted educational material through mini-courses, motivational and practical tips and an embedded library of materials relevant to physical activity, healthy diet and alcohol consumption. To boost motivation, it will also include reminders and gamification features like badges and points.
Sponsors & Collaborators
-
BROSTCANCERFORENINGEN AMAZONA I STOCKHOLMS LAN
collaborator UNKNOWN -
FUNDACION PARA LA INVESTIGACION DEL HOSPITAL CLINICO DE LA COMUNITAT VALENCIANA, FUNDACION INCLIVA
collaborator UNKNOWN -
Instituto de Investigacion Sanitaria INCLIVA
collaborator INDUSTRY -
LIETUVOS SVEIKATOS MOKSLU UNIVERSITETAS
collaborator UNKNOWN -
PAGALBOS ONKOLOGINIAMS LIGONIAMS ASOCIACIJA
collaborator UNKNOWN -
SWPS UNIWERSYTET HUMANISTYCZNOSPOLECZNY
collaborator UNKNOWN -
EUROPEAN FOOD INFORMATION COUNCIL
collaborator UNKNOWN -
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS
collaborator UNKNOWN -
EXUS SOFTWARE MONOPROSOPI ETAIRIA PERIORISMENIS EVTHINIS
collaborator UNKNOWN -
RISA SICHERHEITSANALYSEN GMBH
collaborator UNKNOWN -
BIOASSIST SA
collaborator UNKNOWN -
EUROPEAN HEALTH MANAGEMENT ASSOCIATION
collaborator UNKNOWN -
ETICAS DATA SOCIETY
collaborator UNKNOWN - collaborator OTHER
-
PREDICTBY RESEARCH AND CONSULTING S.L.
collaborator UNKNOWN -
Harokopio University
lead OTHER
Principal Investigators
-
Yannis Manios, Professor · Department of Nutrition and Dietetics, School of Health Science & Education, Harokopio University, Athens, Greece
Study Design
- Allocation
- NA
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-04-22
- Primary Completion
- 2025-09-30
- Completion
- 2025-09-30
Countries
- Greece
- Lithuania
- Spain
- Sweden
Study Locations
More Related Trials
-
Written Genetic Counseling and Mutation Analysis of BRCA1 and BRCA2 to Patients With Breast Cancer
NCT02557776 ·Status: COMPLETED ·Phase: NA
-
Patient Empowerment by Group Medical Consultations
NCT01329068 ·Status: UNKNOWN ·Phase: NA
-
Early Detection of Cardiovascular Changes After Radiotherapy for Breast Cancer
NCT03297346 ·Status: COMPLETED ·Phase: NA
-
International Breast Cancer Biomarker,Standard of Care and Real World Outcomes Study
NCT03078036 ·Status: COMPLETED
-
AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer.
NCT02102165 ·Status: RECRUITING ·Phase: NA
-
Personalised Risk-based Breast Cancer Prevention and Screening
NCT03989258 ·Status: UNKNOWN ·Phase: NA
-
Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood & Primary Tumor in ER+/HER2- MBC
NCT04480814 ·Status: COMPLETED
-
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
NCT06896474 ·Status: RECRUITING ·Phase: NA
-
A Retrospective Analysis of Magnetic Resonance Imaging Data for Breast Cancer Screening in the Open Consortium for Decentralized Medical Artificial Intelligence
NCT05698056 ·Status: ACTIVE_NOT_RECRUITING
-
Brevera™ Breast Biopsy System Data Collection Study
NCT03456583 ·Status: COMPLETED
-
Coronary Artery Calcium and Cardiovascular Risk Factors Analysis After RT or Breast Cancer
NCT05775822 ·Status: COMPLETED ·Phase: NA
-
PRECAMA: Molecular Subtypes of Premenopausal Breast Cancer in Latin American Women
NCT03144648 ·Status: RECRUITING
-
Personalization of Breast Radiotherapy According to Loco-regional Recurrence Risk and Toxicity Probability
NCT06382818 ·Status: RECRUITING ·Phase: NA
-
Intervention to Promote Breast Cancer Screening Among American Indian Women
NCT05530603 ·Status: COMPLETED ·Phase: NA
-
ThermoBreast - Non-contact Breast Cancer Imaging Using AI-enhanced Thermography.
NCT06266026 ·Status: RECRUITING ·Phase: NA
-
Screening Tool Artificial Intelligence-based for Predicting the Genetic Risk of BREAST Cancer
NCT07070128 ·Status: RECRUITING
-
Evaluation of an Online Intervention to Educate Women at High Risk of Breast Cancer on How to Help Reduce Their Risk.
NCT07120087 ·Status: RECRUITING ·Phase: NA
-
Blood Test for Early Detection of Breast Cancer Using Todos Medical -Breast 1(TM-B1) Assay
NCT03343691 ·Status: UNKNOWN
-
Genetic Education in BRCA Families
NCT03544983 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium
NCT02652975 ·Status: COMPLETED ·Phase: NA
-
Predicting Cancer Risk With Digital and Molecular Markers
NCT06962670 ·Status: RECRUITING ·Phase: NA
-
Investigation of Genomic Alteration in Patients With Luminal A or Luminal B Subtypes
NCT04403984 ·Status: UNKNOWN
-
COGNITION: Genomics-Guided Precision Oncology in Early High-Risk Breast Cancer
NCT05906407 ·Status: RECRUITING
-
Personalized Breast Cancer Screening
NCT06060938 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Clinical Investigation to Evaluate Microwave Imaging Via MammoWave® in a Population-based Screening Program for Early Breast Cancer Detection
NCT06291896 ·Status: RECRUITING ·Phase: NA